Volume | 70,948 |
|
|||||
Noticias | - |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
NKGen Biotech Inc | NKGN | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
1.21 | 1.21 | 1.25 | 1.20 | 1.19 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio |
---|---|---|---|---|
359 | 70,948 | US$ 1.23 | US$ 87,294 | - |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
17:33:04 | formt | 100 | US$ 1.21 | USD |
Información Financiera NKGen Biotech Inc NKGN
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
27.14M | 21.89M | - | 0 | -82.95M | -3.79 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre NKGen Biotech Inc NKGN
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
22/2/2024 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
14/2/2024 | 19:19 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:16 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 12:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
22/1/2024 | 05:12 | Edgar (US Regulatory) | Form 8-K - Current report |
08/1/2024 | 16:19 | Edgar (US Regulatory) | Form 8-K - Current report |
28/12/2023 | 15:14 | Edgar (US Regulatory) | Form 8-K - Current report |
27/12/2023 | 15:02 | Edgar (US Regulatory) | Form 8-K - Current report |
27/12/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
19/12/2023 | 12:41 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
Histórico de Datos NKGN
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |